These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17310509)

  • 21. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study.
    Ko SH; Song KH; Park SA; Kim SR; Cha BY; Son HY; Moon KW; Yoo KD; Park YM; Cho JH; Yoon KH; Ahn YB
    Diabet Med; 2008 Oct; 25(10):1171-7. PubMed ID: 19046195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentrations in women with type 2 diabetes.
    Fukui M; Ose H; Nakayama I; Hosoda H; Asano M; Kadono M; Mogami S; Hasegawa G; Yoshikawa T; Nakamura N
    Diabetes Care; 2007 Jul; 30(7):1886-8. PubMed ID: 17363753
    [No Abstract]   [Full Text] [Related]  

  • 23. [Measurement of protein loss in the urine. A useful addition in cardiovascular disease risk assessment].
    Stehouwer CD; Gansevoort RT
    Ned Tijdschr Geneeskd; 2009 Apr; 153(17):796. PubMed ID: 19469210
    [No Abstract]   [Full Text] [Related]  

  • 24. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate.
    Cirillo M; Lanti MP; Menotti A; Laurenzi M; Mancini M; Zanchetti A; De Santo NG
    Arch Intern Med; 2008 Mar; 168(6):617-24. PubMed ID: 18362254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hematuria with or without albuminuria in apparently healthy subjects].
    Bergstrand A; Bucht H; Samuelsson A; Wasserman J
    Minerva Nefrol; 1970; 17(4):151-6. PubMed ID: 5515287
    [No Abstract]   [Full Text] [Related]  

  • 26. What's in a name, AKI?
    Davis CL
    Liver Transpl; 2009 May; 15(5):455-6. PubMed ID: 19399738
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased incidence of kidney diseases in general practice after a nationwide albuminuria self-test program.
    de Borst J; Nielen MM; Verheij RA; Schellevis FG
    BMC Fam Pract; 2011 Aug; 12():81. PubMed ID: 21812999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 30. [The kidneys and diabetes].
    Rüster C; Sämann A; Wolf G
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486
    [No Abstract]   [Full Text] [Related]  

  • 31. New markers for analyzing the cause of hematuria.
    Janssens PM
    Kidney Int Suppl; 1994 Nov; 47():S115-6. PubMed ID: 7532740
    [No Abstract]   [Full Text] [Related]  

  • 32. Information from your family doctor. Treatment options for type 2 diabetes--what's available?
    Am Fam Physician; 2001 May; 63(9):1759-60. PubMed ID: 11352286
    [No Abstract]   [Full Text] [Related]  

  • 33. Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.
    Bakris GL; Kuritzky L
    Postgrad Med; 2009 Jul; 121(4):51-60. PubMed ID: 19641270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transitory proteinuria as a symptom of myeloma].
    Kukhtevich AV; Russkikh AV; Kireeva VI
    Ter Arkh; 2000; 72(6):65-6. PubMed ID: 10900656
    [No Abstract]   [Full Text] [Related]  

  • 36. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
    Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
    Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population.
    Graziani MS; Gambaro G; Mantovani L; Sorio A; Yabarek T; Abaterusso C; Lupo A; Rizzotti P
    Nephrol Dial Transplant; 2009 May; 24(5):1490-4. PubMed ID: 19037085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striking association between urinary cadmium level and albuminuria among Torres Strait Islander people with diabetes.
    Haswell-Elkins M; Satarug S; O'Rourke P; Moore M; Ng J; McGrath V; Walmby M
    Environ Res; 2008 Mar; 106(3):379-83. PubMed ID: 18045586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria.
    Zandbergen AA; Vogt L; de Zeeuw D; Lamberts SW; Ouwendijk RJ; Baggen MG; Bootsma AH
    Diabetes Care; 2007 Dec; 30(12):3119-21. PubMed ID: 17804682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.